<img alt="" src="https://secure.perk0mean.com/184386.png" style="display:none;">

Clinical Trials: Changing with the Times

Understanding Clinical Trials

 

Clinical trials are controlled research studies on human volunteers, aimed at evaluating new treatments or interventions. Researchers use clinical trials to test the efficacy of vaccines, nutrition supplements, medical equipment, and other medical drugs. Health authorities require ethical approvals to ensure trials meet strict safety and efficacy standards. Trials typically begin with small groups, expanding as data proves the intervention's safety and effectiveness.

01 Preparing for Clinical Trials

Preparing for a clinical trial involves stringent oversight and regulatory approvals. Health authorities assess the biomedical composition, potential impact, and relevance of the trial. Approval doesn't guarantee safety, but it enables progress with close monitoring.

Essential Trial Monitoring Factors

Clinical trials for major pharma companies require precise data management to address:

  • Recruitment success rates
  • Adequate and timely distribution of kits
  • Desired outcomes from the trial results

Ethical approval is mandatory, requiring health authorities to weigh risks versus benefits. Following approval, trials typically start with a small group before expanding, allowing researchers to assess efficacy across varying conditions. Trials may involve testing vaccines, supplements, medical devices, or drugs.

A robust monitoring system for clinical trials should track:

  • Regulatory and administrative requirements
  • Temperature control, especially for kit transport
  • Technological infrastructure, such as temperature monitors and mobile devices

Clinical Trial Goals

Trials aim to prove a drug’s efficacy and safety. Key objectives include:

  1. Verifying the product’s safety with minimal interference in body function
  2. Documenting side effects to reduce risks
  3. Assessing the product’s efficacy compared to existing treatments
  4. Enhancing participants' well-being

These elements are essential to progress trials confidently from initial testing to final phases.

 

Why Real-Time Monitoring is Saving Your Clinical Trials

Find out how to save time and resources for your next project.

02 The Trend of Direct-to-Patient Clinical Trials

As the world grapples with the COVID-19 pandemic, there is a need to diversify clinical trials. Physically administering clinical trial products can lead to the spread of disease, especially if the disease is infectious like COVID-19. Currently, there are no clinical trial participants in hospitals and health facilities because healthcare employees are trying to limit human interaction. Advancements in Information technology and logistics now make it possible to deliver clinical trial products to participants.

The Direct-to-Patient (DtP) model delivers the IMP to the participants’ home where they can self-administer. Research institutions employ specialized logistics companies to transport the products to the participants. This supply model moves drug administration centers from the clinical site to homes, effectively eliminating physical contact between clinical researchers and participants. As researchers adopt this new system, they expect to deliver more trial interventions and cover a larger sample area.

The DtP approach involves the following infrastructure: Logistical Networks - The firm mandated to deliver the IMP should work with a network that is able to deliver to the most remote location. Storage - The logistics partners should provide storage facilities which can accommodate the required temperatures for oral and intravenous drugs. If the trial product is a machine or equipment, the logistics company should transport it already assembled. Communication - A telehealth device aids communication between the researcher and the participant. The device can either record and transmit data instantly or serialize for further interpretation.

The DtP approach made clinical trials for COVID-19 highly successful. The trials were able to safely collect input, which medical researchers used to produce vaccines. In conjunction with participants and healthcare workers, DtP adoption was a notable achievement. There are plans underway to expand its use in the future.

 

Direct-to-Patient: The Trend in Clinical Trials

Find out why Direct-to-Patient is the most efficient way to distribute clinical trials.

03 Kit Level Monitoring

In the context of COVID-19, the Direct-to-Patient (DtP) model has become essential, reducing physical contact and limiting the spread of disease during clinical trials. The DtP model delivers investigational medicinal products (IMPs) directly to participants’ homes, allowing them to self-administer and providing a safer, efficient alternative to in-clinic trials.

Logistics and Benefits of the DtP Model

Overseeing Product Delivery: Research institutions collaborate with specialized logistics companies to ensure safe and efficient transportation of trial products, minimizing physical contact between researchers and participants.

Efficient Coordination: The DtP model enables the transition of drug administration from clinical sites to participants’ homes, allowing for a broader geographic reach and larger sample sizes.

Infrastructure Requirements:
  • Logistical Networks: Partnering with logistics firms that can access remote locations is essential for effective product delivery.
  • Temperature-Controlled Storage: Logistics partners must provide facilities that maintain required temperatures for both oral and intravenous drugs.
  • Seamless Communication: Telehealth devices facilitate ongoing communication between researchers and participants, allowing for real-time data reporting or serialization for later analysis.

Impact and Future of DtP in Clinical Trials

DtP enabled COVID-19 vaccine trials to proceed safely and effectively, leveraging remote data collection and reducing patient-healthcare worker interactions. Its success has set the stage for expanded use across various clinical trial types, broadening access and reach for future research. As clinical trial planning evolves, adopting the DtP model will enhance safety, reporting accuracy and overall coordination, paving the way for more effective research in the pharmaceutical and healthcare industries.

Direct-to-Patient: The Trend in Clinical Trials

Find out why Direct-to-Patient is the most efficient way to distribute clinical trials.

 

Kit Level Monitoring: Eliminating Data Collection Headaches

Data collection of clinical trials is giving you a headache? We have the solution for you.

04 Data Collection for Clinical Trials

Logistics and Benefits of the DtP Model

Overseeing Product Delivery: Research institutions collaborate with specialized logistics companies to ensure safe and efficient transportation of trial products, minimizing physical contact between researchers and participants.

Efficient Coordination: The DtP model enables the transition of drug administration from clinical sites to participants’ homes, allowing for a broader geographic reach and larger sample sizes.

Infrastructure Requirements:
  • Logistical Networks: Partnering with logistics firms that can access remote locations is essential for effective product delivery.
  • Temperature-Controlled Storage: Logistics partners must provide facilities that maintain required temperatures for both oral and intravenous drugs.
  • Seamless Communication: Telehealth devices facilitate ongoing communication between researchers and participants, allowing for real-time data reporting or serialization for later analysis.

Data Collection for Clinical Trials

Consider  these subjects before you choose a temperature-monitoring device.

In focus

Clinical Trials Data: Key to Monitoring & Compliance

Selecting the appropriate data logger, temperature indicator, or monitoring device is crucial for ...

Enhance Clinical Trial Data with Temperature Monitoring Tools

The complexity of clinical trials demands efficient, accurate and compliant data collection. As ...

Reporting: What is an audit trail?

What is in the report? Regulations require strict system security. Carefully selected users must ...

The Pharmaceutical Temperature Monitoring Process

Building management systems (BMS) monitor and control power systems, fire systems, security ...

Temperature Monitoring Regulations for Pharmaceuticals

National and international organizations regularly share findings and best practices in order to ...

Industries Most Dependent on Temperature Control

The industries most dependent on temperature monitoring are those that are strictly regulated to ...